Advertisement
Findings add to understanding and guide sigmoidoscopy recommendations
With colorectal cancer (CRC) in patients under age 50 rising 1.5 percent per year, James Church, MD, and his colleagues are working to get to root causes and promote earlier screening for at-risk populations.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
His most recent study produced an important confirmation of how age correlates with different pathways to carcinogenesis. This investigation of tumor biology clearly shows the relationship of age with disparate neoplastic pathways, and with left- vs. right-sided tumors. The findings add to our understanding of CRC etiology and strengthen the case for early sigmoidoscopy in people under 50 who have family histories or other risk factors.
Approximately 25 percent of all CRC is caused by hypermethylation and the remainder from chromosomal instability. Methylation is a normal mechanism for turning gene expression on and off as needed for hormonal and other functions. Hypermethylation, however, results in inappropriate “switching” off of genes, and when tumor suppressor genes are switched off this can initiate a pathway to neoplastic changes (sessile serrated polyps and adenomas as cancer precursors). Methylation-induced cancer is largely right-sided. Smoking is a known high risk factor, and obesity, diet and sedentary lifestyles may be others.
Tumors that originate with an APC mutation develop through chromosomal instability and occur with similar frequency in the right and left side. These tumors represent the majority of all CRC cancers.
Because DNA methylation levels in the colon increase with age, Dr. Church and his colleagues hypothesized that these sort of cancers would be uncommon in young patients. Because methylator cancers are right sided, this could explain the predilection for left sided cancers in the young.
To ferret out the differences between tumors in the younger and older groups, researchers studied frozen slices of 497 colorectal tumors from Cleveland Clinic’s tumor bank. 88.5 percent (440) were from patients over 50, with 11.5 percent (57), 50 years of age or younger. About half were women and half men, in both age groups. Hereditary disease and irritable bowel syndrome cases were excluded from the study.
Incidence of right-sided cancers rose in stair-step fashion with each decade past age 50, starting at 19 percent (<50) and rising to 34 percent (50-60), 52 percent (60-70), 55 percent (70-80), and 71 percent (>80), strengthening the evidence that hypermethlylation is an age-related cause of CRC.
Advertisement
While most CRC is left-sided, the study demonstrates that the incidence of right-sided tumors increases dramatically with age (50 years old and up). This underlines the importance of scheduled 5- or 10-year full colonoscopy for older adults, which is a standard screening recommendation. Further, considering the overall increasing CRC rate in patients under 50, and the relatively low incidence of right-sided cancer in this group, flexible sigmoidoscopy (up to the splenic flexure) represents a sound recommendation for people age 40 to 50.
Dr. Church presented his study Wednesday at the 2018 American Society of Colon and Rectal Surgeons Scientific Meeting.
Advertisement
Advertisement
Polygenic risk score could help predict who will develop this aggressive breast cancer
New guidelines offer insight into emerging therapies, dental issues and more
Clinical trial to assess the value of nutritional, physical therapy and social supports prior to preoperative chemotherapy
Research demonstrates improved overall survival for patients receiving comprehensive treatment for breast cancer in addition to radiation or surgical intervention for brain cancer
Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’
Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates
Extent of baseline burden impacts progression-free and overall survival
Further study warranted to better understand the clinical implications of these findings